 | • レポートコード：MRC2-11QY14436 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は人工関節感染症治療のグローバル市場について調査・分析したレポートです。種類別（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別人工関節感染症治療の競争状況、市場シェア ・世界の人工関節感染症治療市場：種類別市場規模 2015年-2020年（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他） ・世界の人工関節感染症治療市場：種類別市場規模予測 2021年-2026年（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他） ・世界の人工関節感染症治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の人工関節感染症治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の人工関節感染症治療市場分析：米国、カナダ ・ヨーロッパの人工関節感染症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの人工関節感染症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の人工関節感染症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの人工関節感染症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cempra Inc、Motif Bio Plc、Nabriva Therapeutics AG、Telephus Medical LLC、TenNor Therapeutics Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market
The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prosthetic Joint Infections Treatment Scope and Market Size
Prosthetic Joint Infections Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prosthetic Joint Infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Prosthetic Joint Infections Treatment market is segmented into
Fusidic acid
Lefamulin Acetate
MTF-101
TNP-2092
Others
Segment by Application, the Prosthetic Joint Infections Treatment market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Prosthetic Joint Infections Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prosthetic Joint Infections Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prosthetic Joint Infections Treatment Market Share Analysis
Prosthetic Joint Infections Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prosthetic Joint Infections Treatment business, the date to enter into the Prosthetic Joint Infections Treatment market, Prosthetic Joint Infections Treatment product introduction, recent developments, etc.
The major vendors covered:
Cempra Inc
Motif Bio Plc
Nabriva Therapeutics AG
Telephus Medical LLC
TenNor Therapeutics Ltd
…
1 Study Coverage
1.1 Prosthetic Joint Infections Treatment Product Introduction
1.2 Market Segments
1.3 Key Prosthetic Joint Infections Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prosthetic Joint Infections Treatment Market Size Growth Rate by Type
1.4.2 Fusidic acid
1.4.3 Lefamulin Acetate
1.4.4 MTF-101
1.4.5 TNP-2092
1.4.6 Others
1.5 Market by Application
1.5.1 Global Prosthetic Joint Infections Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Prosthetic Joint Infections Treatment Market Size, Estimates and Forecasts
2.1.1 Global Prosthetic Joint Infections Treatment Revenue 2015-2026
2.1.2 Global Prosthetic Joint Infections Treatment Sales 2015-2026
2.2 Global Prosthetic Joint Infections Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Prosthetic Joint Infections Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Prosthetic Joint Infections Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prosthetic Joint Infections Treatment Competitor Landscape by Players
3.1 Prosthetic Joint Infections Treatment Sales by Manufacturers
3.1.1 Prosthetic Joint Infections Treatment Sales by Manufacturers (2015-2020)
3.1.2 Prosthetic Joint Infections Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Prosthetic Joint Infections Treatment Revenue by Manufacturers
3.2.1 Prosthetic Joint Infections Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Prosthetic Joint Infections Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prosthetic Joint Infections Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prosthetic Joint Infections Treatment Revenue in 2019
3.2.5 Global Prosthetic Joint Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Prosthetic Joint Infections Treatment Price by Manufacturers
3.4 Prosthetic Joint Infections Treatment Manufacturing Base Distribution, Product Types
3.4.1 Prosthetic Joint Infections Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prosthetic Joint Infections Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Prosthetic Joint Infections Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prosthetic Joint Infections Treatment Market Size by Type (2015-2020)
4.1.1 Global Prosthetic Joint Infections Treatment Sales by Type (2015-2020)
4.1.2 Global Prosthetic Joint Infections Treatment Revenue by Type (2015-2020)
4.1.3 Prosthetic Joint Infections Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prosthetic Joint Infections Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Prosthetic Joint Infections Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Prosthetic Joint Infections Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Prosthetic Joint Infections Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prosthetic Joint Infections Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Prosthetic Joint Infections Treatment Market Size by Application (2015-2020)
5.1.1 Global Prosthetic Joint Infections Treatment Sales by Application (2015-2020)
5.1.2 Global Prosthetic Joint Infections Treatment Revenue by Application (2015-2020)
5.1.3 Prosthetic Joint Infections Treatment Price by Application (2015-2020)
5.2 Prosthetic Joint Infections Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Prosthetic Joint Infections Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Prosthetic Joint Infections Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Prosthetic Joint Infections Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Prosthetic Joint Infections Treatment by Country
6.1.1 North America Prosthetic Joint Infections Treatment Sales by Country
6.1.2 North America Prosthetic Joint Infections Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Prosthetic Joint Infections Treatment Market Facts & Figures by Type
6.3 North America Prosthetic Joint Infections Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Prosthetic Joint Infections Treatment by Country
7.1.1 Europe Prosthetic Joint Infections Treatment Sales by Country
7.1.2 Europe Prosthetic Joint Infections Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prosthetic Joint Infections Treatment Market Facts & Figures by Type
7.3 Europe Prosthetic Joint Infections Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Prosthetic Joint Infections Treatment by Region
8.1.1 Asia Pacific Prosthetic Joint Infections Treatment Sales by Region
8.1.2 Asia Pacific Prosthetic Joint Infections Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Prosthetic Joint Infections Treatment Market Facts & Figures by Type
8.3 Asia Pacific Prosthetic Joint Infections Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Prosthetic Joint Infections Treatment by Country
9.1.1 Latin America Prosthetic Joint Infections Treatment Sales by Country
9.1.2 Latin America Prosthetic Joint Infections Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Prosthetic Joint Infections Treatment Market Facts & Figures by Type
9.3 Central & South America Prosthetic Joint Infections Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Prosthetic Joint Infections Treatment by Country
10.1.1 Middle East and Africa Prosthetic Joint Infections Treatment Sales by Country
10.1.2 Middle East and Africa Prosthetic Joint Infections Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Prosthetic Joint Infections Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Prosthetic Joint Infections Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Cempra Inc
11.1.1 Cempra Inc Corporation Information
11.1.2 Cempra Inc Description and Business Overview
11.1.3 Cempra Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cempra Inc Prosthetic Joint Infections Treatment Products Offered
11.1.5 Cempra Inc Related Developments
11.2 Motif Bio Plc
11.2.1 Motif Bio Plc Corporation Information
11.2.2 Motif Bio Plc Description and Business Overview
11.2.3 Motif Bio Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Motif Bio Plc Prosthetic Joint Infections Treatment Products Offered
11.2.5 Motif Bio Plc Related Developments
11.3 Nabriva Therapeutics AG
11.3.1 Nabriva Therapeutics AG Corporation Information
11.3.2 Nabriva Therapeutics AG Description and Business Overview
11.3.3 Nabriva Therapeutics AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Products Offered
11.3.5 Nabriva Therapeutics AG Related Developments
11.4 Telephus Medical LLC
11.4.1 Telephus Medical LLC Corporation Information
11.4.2 Telephus Medical LLC Description and Business Overview
11.4.3 Telephus Medical LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Telephus Medical LLC Prosthetic Joint Infections Treatment Products Offered
11.4.5 Telephus Medical LLC Related Developments
11.5 TenNor Therapeutics Ltd
11.5.1 TenNor Therapeutics Ltd Corporation Information
11.5.2 TenNor Therapeutics Ltd Description and Business Overview
11.5.3 TenNor Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Products Offered
11.5.5 TenNor Therapeutics Ltd Related Developments
11.1 Cempra Inc
11.1.1 Cempra Inc Corporation Information
11.1.2 Cempra Inc Description and Business Overview
11.1.3 Cempra Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cempra Inc Prosthetic Joint Infections Treatment Products Offered
11.1.5 Cempra Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Prosthetic Joint Infections Treatment Market Estimates and Projections by Region
12.1.1 Global Prosthetic Joint Infections Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Prosthetic Joint Infections Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Prosthetic Joint Infections Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Prosthetic Joint Infections Treatment Sales Forecast (2021-2026)
12.2.2 North America: Prosthetic Joint Infections Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Prosthetic Joint Infections Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Prosthetic Joint Infections Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Prosthetic Joint Infections Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Prosthetic Joint Infections Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Prosthetic Joint Infections Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Prosthetic Joint Infections Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Prosthetic Joint Infections Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Prosthetic Joint Infections Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Prosthetic Joint Infections Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Prosthetic Joint Infections Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Prosthetic Joint Infections Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Prosthetic Joint Infections Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Prosthetic Joint Infections Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Prosthetic Joint Infections Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Prosthetic Joint Infections Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Prosthetic Joint Infections Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Prosthetic Joint Infections Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Prosthetic Joint Infections Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Prosthetic Joint Infections Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Prosthetic Joint Infections Treatment Market Segments
Table 2. Ranking of Global Top Prosthetic Joint Infections Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prosthetic Joint Infections Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Fusidic acid
Table 5. Major Manufacturers of Lefamulin Acetate
Table 6. Major Manufacturers of MTF-101
Table 7. Major Manufacturers of TNP-2092
Table 8. Major Manufacturers of Others
Table 9. Global Prosthetic Joint Infections Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Prosthetic Joint Infections Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Prosthetic Joint Infections Treatment Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Prosthetic Joint Infections Treatment Sales Market Share by Regions (2015-2020)
Table 13. Global Prosthetic Joint Infections Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Prosthetic Joint Infections Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Prosthetic Joint Infections Treatment Sales Share by Manufacturers (2015-2020)
Table 16. Global Prosthetic Joint Infections Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Prosthetic Joint Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prosthetic Joint Infections Treatment as of 2019)
Table 18. Prosthetic Joint Infections Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Prosthetic Joint Infections Treatment Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Prosthetic Joint Infections Treatment Price (2015-2020) (USD/Pcs)
Table 21. Prosthetic Joint Infections Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Prosthetic Joint Infections Treatment Product Type
Table 23. Date of International Manufacturers Enter into Prosthetic Joint Infections Treatment Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Prosthetic Joint Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 26. Global Prosthetic Joint Infections Treatment Sales Share by Type (2015-2020)
Table 27. Global Prosthetic Joint Infections Treatment Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Prosthetic Joint Infections Treatment Revenue Share by Type (2015-2020)
Table 29. Prosthetic Joint Infections Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Prosthetic Joint Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 31. Global Prosthetic Joint Infections Treatment Sales Share by Application (2015-2020)
Table 32. North America Prosthetic Joint Infections Treatment Sales by Country (2015-2020) (K Pcs)
Table 33. North America Prosthetic Joint Infections Treatment Sales Market Share by Country (2015-2020)
Table 34. North America Prosthetic Joint Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Prosthetic Joint Infections Treatment Revenue Market Share by Country (2015-2020)
Table 36. North America Prosthetic Joint Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 37. North America Prosthetic Joint Infections Treatment Sales Market Share by Type (2015-2020)
Table 38. North America Prosthetic Joint Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 39. North America Prosthetic Joint Infections Treatment Sales Market Share by Application (2015-2020)
Table 40. Europe Prosthetic Joint Infections Treatment Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Prosthetic Joint Infections Treatment Sales Market Share by Country (2015-2020)
Table 42. Europe Prosthetic Joint Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Prosthetic Joint Infections Treatment Revenue Market Share by Country (2015-2020)
Table 44. Europe Prosthetic Joint Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Prosthetic Joint Infections Treatment Sales Market Share by Type (2015-2020)
Table 46. Europe Prosthetic Joint Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Prosthetic Joint Infections Treatment Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Prosthetic Joint Infections Treatment Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Prosthetic Joint Infections Treatment Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Prosthetic Joint Infections Treatment Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Prosthetic Joint Infections Treatment Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Prosthetic Joint Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Prosthetic Joint Infections Treatment Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Prosthetic Joint Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Prosthetic Joint Infections Treatment Sales Market Share by Application (2015-2020)
Table 56. Latin America Prosthetic Joint Infections Treatment Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Prosthetic Joint Infections Treatment Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Prosthetic Joint Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Prosthetic Joint Infections Treatment Revenue Market Share by Country (2015-2020)
Table 60. Latin America Prosthetic Joint Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Prosthetic Joint Infections Treatment Sales Market Share by Type (2015-2020)
Table 62. Latin America Prosthetic Joint Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Prosthetic Joint Infections Treatment Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Prosthetic Joint Infections Treatment Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Prosthetic Joint Infections Treatment Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Prosthetic Joint Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Prosthetic Joint Infections Treatment Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Prosthetic Joint Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Prosthetic Joint Infections Treatment Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Prosthetic Joint Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Prosthetic Joint Infections Treatment Sales Market Share by Application (2015-2020)
Table 72. Cempra Inc Corporation Information
Table 73. Cempra Inc Description and Major Businesses
Table 74. Cempra Inc Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Cempra Inc Product
Table 76. Cempra Inc Recent Development
Table 77. Motif Bio Plc Corporation Information
Table 78. Motif Bio Plc Description and Major Businesses
Table 79. Motif Bio Plc Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Motif Bio Plc Product
Table 81. Motif Bio Plc Recent Development
Table 82. Nabriva Therapeutics AG Corporation Information
Table 83. Nabriva Therapeutics AG Description and Major Businesses
Table 84. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Nabriva Therapeutics AG Product
Table 86. Nabriva Therapeutics AG Recent Development
Table 87. Telephus Medical LLC Corporation Information
Table 88. Telephus Medical LLC Description and Major Businesses
Table 89. Telephus Medical LLC Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Telephus Medical LLC Product
Table 91. Telephus Medical LLC Recent Development
Table 92. TenNor Therapeutics Ltd Corporation Information
Table 93. TenNor Therapeutics Ltd Description and Major Businesses
Table 94. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. TenNor Therapeutics Ltd Product
Table 96. TenNor Therapeutics Ltd Recent Development
Table 97. Global Prosthetic Joint Infections Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Prosthetic Joint Infections Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Prosthetic Joint Infections Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Prosthetic Joint Infections Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Prosthetic Joint Infections Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Prosthetic Joint Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Prosthetic Joint Infections Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Prosthetic Joint Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Prosthetic Joint Infections Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Prosthetic Joint Infections Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Prosthetic Joint Infections Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Prosthetic Joint Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Prosthetic Joint Infections Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Prosthetic Joint Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Prosthetic Joint Infections Treatment Players
Table 115. Prosthetic Joint Infections Treatment Customers List
Table 116. Prosthetic Joint Infections Treatment Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Prosthetic Joint Infections Treatment Product Picture
Figure 2. Global Prosthetic Joint Infections Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Fusidic acid Product Picture
Figure 4. Lefamulin Acetate Product Picture
Figure 5. MTF-101 Product Picture
Figure 6. TNP-2092 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Prosthetic Joint Infections Treatment Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Prosthetic Joint Infections Treatment Report Years Considered
Figure 13. Global Prosthetic Joint Infections Treatment Market Size 2015-2026 (US$ Million)
Figure 14. Global Prosthetic Joint Infections Treatment Sales 2015-2026 (K Pcs)
Figure 15. Global Prosthetic Joint Infections Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Prosthetic Joint Infections Treatment Sales Market Share by Region (2015-2020)
Figure 17. Global Prosthetic Joint Infections Treatment Sales Market Share by Region in 2019
Figure 18. Global Prosthetic Joint Infections Treatment Revenue Market Share by Region (2015-2020)
Figure 19. Global Prosthetic Joint Infections Treatment Revenue Market Share by Region in 2019
Figure 20. Global Prosthetic Joint Infections Treatment Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Prosthetic Joint Infections Treatment Revenue in 2019
Figure 22. Prosthetic Joint Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Prosthetic Joint Infections Treatment Sales Market Share by Type (2015-2020)
Figure 24. Global Prosthetic Joint Infections Treatment Sales Market Share by Type in 2019
Figure 25. Global Prosthetic Joint Infections Treatment Revenue Market Share by Type (2015-2020)
Figure 26. Global Prosthetic Joint Infections Treatment Revenue Market Share by Type in 2019
Figure 27. Global Prosthetic Joint Infections Treatment Market Share by Price Range (2015-2020)
Figure 28. Global Prosthetic Joint Infections Treatment Sales Market Share by Application (2015-2020)
Figure 29. Global Prosthetic Joint Infections Treatment Sales Market Share by Application in 2019
Figure 30. Global Prosthetic Joint Infections Treatment Revenue Market Share by Application (2015-2020)
Figure 31. Global Prosthetic Joint Infections Treatment Revenue Market Share by Application in 2019
Figure 32. North America Prosthetic Joint Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Prosthetic Joint Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Prosthetic Joint Infections Treatment Sales Market Share by Country in 2019
Figure 35. North America Prosthetic Joint Infections Treatment Revenue Market Share by Country in 2019
Figure 36. U.S. Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Prosthetic Joint Infections Treatment Market Share by Type in 2019
Figure 41. North America Prosthetic Joint Infections Treatment Market Share by Application in 2019
Figure 42. Europe Prosthetic Joint Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Prosthetic Joint Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Prosthetic Joint Infections Treatment Sales Market Share by Country in 2019
Figure 45. Europe Prosthetic Joint Infections Treatment Revenue Market Share by Country in 2019
Figure 46. Germany Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Prosthetic Joint Infections Treatment Market Share by Type in 2019
Figure 57. Europe Prosthetic Joint Infections Treatment Market Share by Application in 2019
Figure 58. Asia Pacific Prosthetic Joint Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Prosthetic Joint Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Prosthetic Joint Infections Treatment Sales Market Share by Region in 2019
Figure 61. Asia Pacific Prosthetic Joint Infections Treatment Revenue Market Share by Region in 2019
Figure 62. China Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Prosthetic Joint Infections Treatment Market Share by Type in 2019
Figure 85. Asia Pacific Prosthetic Joint Infections Treatment Market Share by Application in 2019
Figure 86. Latin America Prosthetic Joint Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Prosthetic Joint Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Prosthetic Joint Infections Treatment Sales Market Share by Country in 2019
Figure 89. Latin America Prosthetic Joint Infections Treatment Revenue Market Share by Country in 2019
Figure 90. Mexico Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Prosthetic Joint Infections Treatment Market Share by Type in 2019
Figure 97. Latin America Prosthetic Joint Infections Treatment Market Share by Application in 2019
Figure 98. Middle East and Africa Prosthetic Joint Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Prosthetic Joint Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Prosthetic Joint Infections Treatment Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Prosthetic Joint Infections Treatment Revenue Market Share by Country in 2019
Figure 102. Turkey Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Prosthetic Joint Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Prosthetic Joint Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Prosthetic Joint Infections Treatment Market Share by Type in 2019
Figure 109. Middle East and Africa Prosthetic Joint Infections Treatment Market Share by Application in 2019
Figure 110. North America Prosthetic Joint Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Prosthetic Joint Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Prosthetic Joint Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Prosthetic Joint Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Prosthetic Joint Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
壊死性皮膚感染症治療の世界市場（～2026年） Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly c…- 目感染症治療の世界市場（～2026年） Eye infections can be the inflammation of the Conjunctiva (Conjunctivitis), eyelid (blepharitis), the cornea (keratitis), the liquid inside the eye (vitritis), the retina and the blood vessels that feed it (chorioretinitis), or the optic nerve (neuroretinitis). Eye infections treatment market is gro…
- ナイセリア淋菌感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Neisseria Gonorrhoeae Infections Treatment Market The global Neisseria Gonorrhoeae Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Neisseria Gonorrhoeae Infecti…
- エプスタインバーウイルス（HHV-4）感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Epstein-Barr Virus (HHV-4) Infections Treatment Market The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Epstein-Barr Virus …
- 医療関連感染（HAI）診断の世界市場（～2026年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…